Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Total Debt (2025)

Zenas BioPharma has reported Total Debt over the past 1 years, most recently at $78.6 million for Q4 2025.

  • Quarterly results put Total Debt at $78.6 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $78.6 million (changed N/A YoY), and the annual figure for FY2025 was $78.6 million, changed.
  • Total Debt for Q4 2025 was $78.6 million at Zenas BioPharma, up from $73.0 million in the prior quarter.
  • Over the last five years, Total Debt for ZBIO hit a ceiling of $78.6 million in Q4 2025 and a floor of $73.0 million in Q3 2025.